indapamide has been researched along with Hypoglycemia in 4 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We sought to estimate individual beneficial and adverse effects of intensive glucose control in patients with type 2 diabetes." | 1.43 | Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes. ( Chalmers, J; Grobbee, DE; Harrap, S; Heller, S; Mancia, G; Marre, M; Poulter, N; van der Graaf, Y; van der Leeuw, J; Visseren, FL; Woodward, M; Zoungas, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, MG | 1 |
| Perkovic, V | 1 |
| Chalmers, J | 3 |
| Woodward, M | 3 |
| Li, Q | 1 |
| Cooper, ME | 1 |
| Hamet, P | 2 |
| Harrap, S | 2 |
| Heller, S | 2 |
| MacMahon, S | 2 |
| Mancia, G | 3 |
| Marre, M | 2 |
| Matthews, D | 1 |
| Neal, B | 2 |
| Poulter, N | 3 |
| Rodgers, A | 1 |
| Williams, B | 1 |
| Zoungas, S | 3 |
| van der Leeuw, J | 1 |
| Visseren, FL | 1 |
| van der Graaf, Y | 1 |
| Grobbee, DE | 2 |
| de Galan, BE | 1 |
| Anderson, C | 1 |
| Dufouil, C | 1 |
| Pillai, A | 1 |
| Cooper, M | 1 |
| Hackett, M | 1 |
| Heller, SR | 1 |
| Lisheng, L | 1 |
| Pan, CY | 1 |
| Patel, A | 1 |
| Travert, F | 1 |
| Thomsen, JF | 1 |
| Feldt-Rasmussen, BF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study[NCT00949286] | 8,494 participants (Actual) | Observational | 2010-01-31 | Completed | |||
| ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation[NCT00145925] | Phase 3 | 11,140 participants (Actual) | Interventional | 2001-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for indapamide and Hypoglycemia
| Article | Year |
|---|---|
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combin | 2016 |
3 other studies available for indapamide and Hypoglycemia
| Article | Year |
|---|---|
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
Topics: Aged; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations | 2016 |
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Topics: Aged; Antihypertensive Agents; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Diabetic A | 2009 |
[Severe hypokalemia and hyperglycemia developed during indapamide therapy].
Topics: Humans; Hypoglycemia; Hypokalemia; Indapamide; Male; Middle Aged | 1991 |